Oxygenta Pharmaceutical Ltd vs Smruthi Organics Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Oxygenta Pharmaceutical Ltd is ₹ 55.21 as of 05 May 15:30 . The P/E Ratio of Oxygenta Pharmaceutical Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Smruthi Organics Ltd changed from 14.9 on March 2021 to 35.5 on March 2025 . This represents a CAGR of 18.96% over 5 years The Market Cap of Oxygenta Pharmaceutical Ltd changed from ₹ 34.15 crore on March 2022 to ₹ 294.24 crore on March 2025 . This represents a CAGR of 71.33% over 4 yearsThe Market Cap of Smruthi Organics Ltd changed from ₹ 254.45 crore on March 2021 to ₹ 126.2 crore on March 2025 . This represents a CAGR of -13.09% over 5 years The revenue of Oxygenta Pharmaceutical Ltd for the Dec '25 is ₹ 33.93 crore as compare to the Sep '25 revenue of ₹ 14.25 crore. This represent the growth of 138.11% The revenue of Smruthi Organics Ltd for the Dec '25 is ₹ 22.3 crore as compare to the Sep '25 revenue of ₹ 31.61 crore. This represent the decline of -29.45% The ebitda of Oxygenta Pharmaceutical Ltd for the Dec '25 is ₹ -4.08 crore as compare to the Sep '25 ebitda of ₹ -4.63 crore. This represent the decline of -11.88% The ebitda of Smruthi Organics Ltd for the Dec '25 is ₹ 3.56 crore as compare to the Sep '25 ebitda of ₹ 5.02 crore. This represent the decline of -29.08% The net profit of Oxygenta Pharmaceutical Ltd changed from ₹ -1.36 crore to ₹ -4.84 crore over 7 quarters. This represents a CAGR of 106.55% The net profit of Smruthi Organics Ltd changed from ₹ -0.92 crore to ₹ 1.4 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Oxygenta Pharmaceutical Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Smruthi Organics Ltd changed from 20.08 % on March 2021 to 48.24 % on March 2025 . This represents a CAGR of 19.16% over 5 years .

About Oxygenta Pharmaceutical Ltd

Oxygenta Pharmaceutical Limited was initially incorporated as S S Organics Private Limited as a private limited Company in 1990.
The Company converted its status to a Public Limited Company in 1993 changing the name to S S Organics Limited.
Further, it was changed to Oxygenta Pharmaceutical Limited in FY 2021-22. The Company was incorporated with the objective of carrying on the business of manufacturing all classes and kinds of Drugs including Pharmaceutical preparation, and Organic Fine Chemicals.
It manufactures a wide range of new generation quinolones, antiasthmatic, antiulcerant, and anti-inflammatory drugs.
The Company has plant located at Medak in Andhra Pradesh. The Company is strong in manufacturing of anti ulcerative and anti bacterial drugs.

About Smruthi Organics Ltd

Smruthi Organics Limited was incorporated in July, 1989 as a Private Limited Company and was subsequently converted into a Public Limited Company in February, 1995.
The Company was promoted by E Purushotham and Shankarrao R Myakal.
The Company is a manufacturer of Active Pharmaceutical Ingredient (API) products in the Anti - Diabetic, Anti - Hypertension and Anti - Infectives Therapeutic categories catering to both the Indian domestic as well as rest of the world (ROW) markets, with clients spanning across Asia, Americas, and Africa.
It has 2 manufacturing facilities in Solapur, India. The Company set up a plant at Solapur, Maharashtra, to manufacture bulk drugs like diloxanide furoate (inst. cap. : 24 tpa) and sulphadiazine (inst. cap. : 36 tpa).
It expanded its activities and product range in 1993-94 by manufacturing metronidazole benzoate, tinidazole, paracetamol and norfloxacin.

FAQs for the comparison of Oxygenta Pharmaceutical Ltd and Smruthi Organics Ltd

Which company has a larger market capitalization, Oxygenta Pharmaceutical Ltd or Smruthi Organics Ltd?

Market cap of Oxygenta Pharmaceutical Ltd is 204 Cr while Market cap of Smruthi Organics Ltd is 132 Cr

What are the key factors driving the stock performance of Oxygenta Pharmaceutical Ltd and Smruthi Organics Ltd?

The stock performance of Oxygenta Pharmaceutical Ltd and Smruthi Organics Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Oxygenta Pharmaceutical Ltd and Smruthi Organics Ltd?

As of May 5, 2026, the Oxygenta Pharmaceutical Ltd stock price is INR ₹55.21. On the other hand, Smruthi Organics Ltd stock price is INR ₹116.05.

How do dividend payouts of Oxygenta Pharmaceutical Ltd and Smruthi Organics Ltd compare?

To compare the dividend payouts of Oxygenta Pharmaceutical Ltd and Smruthi Organics Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.